ISSN: 1230-2813
Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
vol. 27
Original article

Addenbrooke’s Cognitive Examination-III (ACE-III) test as a new potential tool for screening of cognitive dysfunctions in the course of multiple sclerosis

Małgorzata Figlus, Magdalena Obrembska, Elżbieta Miller, Andrzej Głąbiński

Adv Psychiatry Neurol 2018; 27 (4): 281-288
Online publish date: 2018/11/14
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
Cognitive dysfunction occurs in more than half of patients with multiple sclerosis (MS). The evaluation of the level of cognitive functioning in MS patients is important for the assessment of the disease course and deciding on appropriate therapeutic interventions. The purpose of the study was to analyse the suitability of the Addenbrooke’s Cognitive Examination-III (ACE-III) as a screening tool for detecting cognitive dysfunctions in MS.

The study included 28 MS patients and 24 age- and gender-matched controls. The evaluation of cognitive functioning was conducted with ACE-III. The results were subjected to statistical analysis expanded by determining the optimal cut-off points for individual subscales of the test.

The level of all cognitive functions was lower in MS patients. Statistically significant differences (p < 0.005) were demonstrated for the results of the ACE-III total score, memory, Mini-ACE (M-ACE) and fluency. The highest AUC values were obtained for total score, memory, M-ACE and fluency. With the cut-off level of 97 points, the test was characterised by sensitivity of 75% and specificity of over 95%. In terms of memory and fluency, the test was characterised by sensitivity close to 60% and specificity over 90%.

The ACE-III presents high diagnostic accuracy, good sensitivity and diagnostic specificity in the assessment of cognitive dysfunctions in MS. The results of the study concerning the deteriorated functioning of MS patients in terms of memory and fluency coincide with the conclusions from the literature and are an attempt to characterise the profile of cognitive dysfunctions in MS patients.


multiple sclerosis, cognitive dysfunction, neurocognitive test

Guenter W, Jabłońska J, Bieliński M, Borkowska A. Neuroobrazowe i genetyczne korelaty zaburzeń funkcji poznawczych w przebiegu stwardnienia rozsianego. Psychiatr Pol 2015; 49: 897-910.
Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology 2000; 55: 1613-1620.
Matias-Guiu JA, Cortés-Martínez A, Valles-Salgado M, et al. Addenbrooke’s cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests. Int Psychogeriatr 2017; 29: 105-113.
Hsieh S, McGrory S, Leslie F, et al. The Mini-Addenbrooke’s Cognitive Examination: a new assessment tool for dementia. Dement Geriatr Cogn Disord 2015; 39: 1-11.
Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord 2013; 36: 242-250.
Pendlebury ST, Mariz J, Bull L, Mehta Z, Rothwell PM. MoCA, ACE-R, and MMSE versus the National Institute of Neurological Disorders and Stroke – Canadian Stroke Network vascular cognitive impairment harmonization standards neuropsychological battery after TIA and stroke. Stroke 2012; 43: 464-469.
Velayudhan L, Ryu SH, Raczek M, et al. Review of brief cognitive tests for patients with suspected dementia. Int Psychogeriatr 2014; 26: 1247-1262.
Giebel CM, Challis D. Sensitivity of the Mini-Mental State Examination, Montreal Cognitive Assessment and the Addenbrooke’s Cognitive Examination III to everyday activity impairments in dementia: an exploratory study. Int J Geriatr Psychiatry 2017; 32: 1085-1093.
Matías-Guiu JA, Valles-Salgado M, Rognoni T, Hamre-Gil F, Moreno-Ramos T, Matías-Guiu J. Comparative diagnostic accuracy of the ACE-III, MIS, MMSE, MoCA, and RUDAS for screening of Alzheimer Disease. Dement Geriatr Cogn Disord 2017; 43: 237-246.
DeSousa EA, Albert RH, Kalman B. Cognitive impairments in multiple sclerosis: a review. Am J Alzheimers Dis Other Demen 2002; 17: 23-29.
Ferreira ML. Cognitive deficits in multiple sclerosis: a systematic review. Arq Neuropsiquiatr 2010; 68: 632-641.
Johnen A, Landmeyer NC, Bürkner PC, Wiendl H, Meuth SG, Holling H. Distinct cognitive impairments in different disease courses of multiple sclerosis – A systematic review and meta-analysis. Neurosci Biobehav Rev 2017; 83: 568-578.
Rock PL, Roiser JP, Riedel WJ, Blackwell AD. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med 2014; 44: 2029-2040.
Sitek EJ, Barczak A, Senderecka M. Zastosowanie jakościowej analizy profilu wykonania skali ACE-III w diagnostyce różnicowej chorób otępiennych. Aktualności Neurologiczne 2017; 17: 34-41.
Pravatà E, Rocca MA, Valsasina P, et al. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis. Mult Scler J 2017; 23: 1864-1874.
Amaral-Carvalho V, Caramelli P. Normative data for healthy middle-aged and elderly performance on the Addenbrooke Cognitive Examination-Revised. Cogn Behav Neurol 2012; 25: 72-76.
Singh-Manoux A, Kivimaki M, Glymour MM, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ 2012; 344: d7622.
Benedict RHB, DeLuca J, Enzinger C, Geurts JJG, Krupp LB, Rao SM. Neuropsychology of Multiple Sclerosis: Looking Back and Moving Forward. J Int Neuropsychol Soc 2017; 23: 832-842.
Laws KR, Irvine K, Gale TM. Sex differences in cognitive impairment in Alzheimer’s disease. World J Psychiatry 2016; 6: 54-65.
Gałecki P, Talarowska M. Poznanie, emocje, depresja, procesy zapalne – podstawowe założenia teorii neurorozwojowej depresji. Neuropsychiatry and Neuropsychology 2017; 12: 30-37.
Lees RA, Hendry Ba K, Broomfield N, Stott D, Larner AJ, Quinn TJ. Cognitive assessment in stroke: feasibility and test properties
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe